Independent report · Venture Capital

Plum: Series B of ₹193 Cr led by Peak XV Partners

· By Reena

Plum's founders, in a photograph published by Inc42 with its report on the Series B. · Image: Inc42

Plum's founders, in a photograph published by Inc42 with its report on the Series B. · Image: Inc42

Independent report content

COMPANYPlum, Bengaluru: employee health benefits and group health insurance platform, founded 2019 by Abhishek Poddar (co-founder and CEO) and Saurabh Arora
ROUNDSeries B of ₹193 Cr, about US$20.5m (Entrepreneur India) or US$20.6m (Inc42, fintech.global) · announced 26 March 2026 · the brief said 2025; the sources say 2026
INVESTORSPeak XV Partners (lead, existing) · Tanglin Venture Partners (existing, higher stake) · GMO VenturePartners, Japan (new)
VALUATION AND STAKESNot published
USE OF FUNDSTalent, technology and enterprise-grade security, AI-driven claims operations, HR and payroll integrations, preventive, primary, mental wellness and telehealth care
SCALE (COMPANY)6,000+ organisations · 600,000+ employees covered · 500,000+ claims processed · NPS 79 (fintech.global)
PROFITABILITYCompany claims its first full year of EBITDA and cash-flow profitability; no year or figures published
PRIOR ROUNDSeries A of about US$15.6m led by Tiger Global, announced around 31 May 2021 (a fintech.global link is dated January 2021)
THE ACCESS POINT Plum is privately held and no listing is reported in the sources read. Employees reach its cover through an employer's group policy, and its consumer pages list Max Bupa and Star Health for personal plans.

Executive decision summary

THE BOTTOM LINEPlum is a Bengaluru platform that sells and manages group health insurance for employers, and on 26 March 2026 it announced a ₹193 crore Series B led by Peak XV Partners. The round is dated 2026, not 2025 as the research brief stated. Tanglin Venture Partners increased its stake and GMO VenturePartners of Japan joined as a new investor. Valuation, stakes and structure are not published. Plum says it reached its first full year of EBITDA and cash-flow profitability, but gives no year or figure. The only financial figures found, on Inc42's data page for FY25, conflict: one section shows revenue of ₹69.9 crore and the other ₹13.9 crore. The insurers behind Plum's group policies are not named in any page read, and no source links Universal Sompo, Edelweiss or Tokio to Plum.
WHICH INVESTORPlum fits a private-markets watch-list IF you want a venture-backed insurtech with a recognised lead investor and a large employer client base. Wait IF you need a published valuation, audited revenue and profit, or the names of the insurers that carry the risk: none was found.
COMFORT FITGroup health insurance = one policy that covers many employees under their employer. Series B = the second major venture round after the first, usually used to scale a proven product. EBITDA = operating profit before interest, tax, depreciation and amortisation. TPA = a third-party administrator that handles insurance claims on behalf of insurers.
THE RUPEIA NUMBER₹193 Cr. The size of Plum's Series B, announced on 26 March 2026 and led by Peak XV Partners, about US$20.5 to 20.6 million.

1 CLAIM REGISTER: EVIDENCE GRADING

ClaimSourceGradeRupeia assessment
Series B of ₹193 Cr led by Peak XV, 26 March 2026Inc42; StartupTalky; Entrepreneur India; fintech.globalBEstablished; the brief's 2025 date was wrong
US$20.5m or US$20.6m equivalentEntrepreneur India; Inc42 and fintech.globalBBoth shown; the difference is rounding or rate
Tanglin (existing, higher stake) and GMO VenturePartners (new)Inc42; StartupTalkyBEstablished
Valuation, stakes and structureAll pages readDNot published
First full year of EBITDA and cash-flow profitabilityCompany claim via 2026 coverageDNo year or figures published
FY25 revenue ₹69.9 Cr and ₹13.9 CrInc42 financials pageDTwo figures on one page conflict
6,000+ organisations, 600,000+ employees, 500,000+ claimsStartupTalky; Entrepreneur India; Inc42CCompany figures, no methodology
Series A of about US$15.6m led by Tiger Global, 2021Entrepreneur India (2021); fintech.global headlineBEstablished; announcement date differs by source
Universal Sompo, Edelweiss or Tokio as Plum insurersNone foundDNo source; insurers not published

2 THE SERIES B ROUND

ItemDetail
Amount₹193 Cr; US$20.5m per Entrepreneur India, US$20.6m per Inc42 and fintech.global
Date26 March 2026 (Inc42, Entrepreneur India, fintech.global)
LeadPeak XV Partners, an existing investor per Inc42; GV Ravishankar, Managing Director, is quoted in the announcement (StartupTalky)
Other investorsTanglin Venture Partners (existing, increased stake); GMO VenturePartners, Japan (new)
Stakes, valuation, structureNot published (Entrepreneur India notes stakes were not disclosed)
Use of fundsTalent; technology and enterprise-grade security; AI-driven claims operations; HR and payroll integrations; preventive, primary, mental wellness and telehealth care (Inc42). fintech.global adds reaching 10 million people
Calculation (Rupeia)Result
Exchange rate implied by Entrepreneur India₹1,930 million ÷ US$20.5 million = ₹94.1 per US$
Exchange rate implied by Inc42 and fintech.global₹1,930 million ÷ US$20.6 million = ₹93.7 per US$
Round at ₹96.5 per US$₹1,930 million ÷ ₹96.5 = US$20.0 million
Round against the FY25 revenue of ₹69.9 Cr₹193 Cr ÷ ₹69.9 Cr = 2.76x
Round against the FY25 revenue of ₹13.9 Cr₹193 Cr ÷ ₹13.9 Cr = 13.9x
RUPEIA READ The round is confirmed by four sources, and the two dollar figures reflect the exchange rate used when the news was written. At today's ₹96.5 the round is about US$20.0 million. The most important missing piece is the price: without a valuation the size of the stake that new investors bought cannot be known.

3 PRIOR FUNDING AND THE VALUATION GAP

ItemDetailSource
Series A sizeAbout US$15.6m (Entrepreneur India, fintech.global); about US$15.7m (Entrackr, search snippet)Entrepreneur India 2021; snippets
Series A leadTiger Global; Entrackr puts Tiger at about US$10mEntrackr, snippet
Other Series A participantsSurge, Tanglin, Incubate Fund, GembaSearch snippets
Series A dateAround 31 May 2021; the fintech.global link carries 6 January 2021Conflict between sources
Series A post-moneyAbout US$87m, Entrackr's own estimate; not company-publishedEntrackr, snippet
Series B valuationNot publishedAll pages read
Calculation (Rupeia)Result
Series A plus Series B (Entrepreneur India figures)US$15.6m + US$20.5m = US$36.1m; earlier funding is not in the sources read
Series B against Series A20.5 ÷ 15.6 = 1.31x
Tiger Global share of the Series A10 ÷ 15.7 = 63.7%
Series A stake at the estimated post-money15.7 ÷ 87 = 18.0%
Gap between the rounds5 × 12 = 60 months of whole years; 58 months from May 2021 (two months short), 62 months from January 2021 (two months over)
Illustration only: post-money if US$20.5m bought 10%, 15% or 20%20.5 ÷ 0.10 = US$205m; 20.5 ÷ 0.15 = US$136.7m; 20.5 ÷ 0.20 = US$102.5m
RUPEIA READ The Series B is 1.31 times the Series A in dollars, which is steady growth in round size over about five years. The illustration spans about US$103 million to US$205 million depending on a stake that is not published; these are arithmetic examples, not reported figures.

4 SCALE AND CUSTOMERS

MeasureFigureSource
Organisations served6,000+StartupTalky; Entrepreneur India
Employees covered600,000+StartupTalky; Entrepreneur India
Claims processed500,000+Inc42; StartupTalky
Net Promoter Score79fintech.global
Reach target10 million peoplefintech.global
Named clientsCRED, Meesho, PhonePe, Swiggy, Tata CLiQ, Urban Company, WeWork, Zomato; Atlassian (Inc42 only)Inc42; StartupTalky
Calculation (Rupeia)Result
Employees per organisation600,000 ÷ 6,000 = 100
Claims per covered employee500,000 ÷ 600,000 = 0.83
Reach target against current cover10,000,000 ÷ 600,000 = 16.7x
Round per covered employee₹1,930 million ÷ 0.6 million = ₹3,217
Named clients8 + 1 = 9 (Atlassian is listed by Inc42 only)
RUPEIA READ An average of 100 covered employees per organisation points to many mid-sized employers, though the named clients are well-known technology and consumer companies. The 10 million figure is a target with no stated timeline or method, not current coverage. All scale figures are company claims.

5 FINANCIALS: TWO SETS OF FY25 FIGURES

Inc42 FY25 (year to March 2025)FAQ sectionSummary box
Revenue₹69.9 Cr (₹45.3 Cr in FY24)₹13.9 Cr (up 14%)
LossNet loss ₹14.0 CrPAT −₹12.2 Cr
EBITDAEstimated −₹12.6 CrNot given
Expenses and assetsNot givenExpenses ₹26.1 Cr; total assets ₹76.3 Cr
Calculation (Rupeia)Result
FAQ revenue growth₹69.9 Cr ÷ ₹45.3 Cr = 1.543x, so growth of 54.3%
FAQ net loss margin₹14.0 Cr ÷ ₹69.9 Cr = 20.0%
FAQ EBITDA margin₹12.6 Cr ÷ ₹69.9 Cr = 18.0%
Summary box: revenue less expenses₹13.9 Cr − ₹26.1 Cr = −₹12.2 Cr, matching its PAT
Summary box loss margin₹12.2 Cr ÷ ₹13.9 Cr = 87.8%
Gap between the two revenue figures₹69.9 Cr − ₹13.9 Cr = ₹56.0 Cr; ₹69.9 Cr ÷ ₹13.9 Cr = 5.0x
Round against the summary-box loss₹193 Cr ÷ ₹12.2 Cr = 15.8 years at that loss
RUPEIA READ The summary-box figures are consistent with each other, and so are the FAQ figures, but the two sets cannot both be right: revenue differs five-fold. Inc42 says its data comes from public filings; the figures were not checked against registrar filings. Both sets show a loss in FY25, so the 2026 profitability claim refers to a later, unquantified period.

6 PEOPLE AND ORIGINS

Person or itemDetailSource
Abhishek PoddarCo-founder and CEO of Plum; a 2021 snippet describes a Stanford alumnus who worked at Google and McKinseyInc42; StartupTalky; Entrackr snippet
Saurabh AroraCo-founder; title not stated in 2026 coverage; a 2021 snippet says they led product and engineering at Freshworks and built AirwootSnippet
GV RavishankarManaging Director, Peak XV Partners, quoted in the 2026 announcementStartupTalky
Founding date2019 (Inc42, Entrepreneur India); early 2020 (Entrackr)Conflict
Calculation (Rupeia)Result
Company age at the Series B, 2019 start2026 − 2019 = 7 years
Company age at the Series B, 2020 start2026 − 2020 = 6 years
Days from announcement to this note228 days, from 26 March to 9 November 2026
RUPEIA READ The same two founders are named from the Series A to the Series B. The founding year is a minor conflict between sources, and the 2021 biographies come from search snippets, not full pages.

7 INSURERS, COMPETITORS AND IRDAI CONTEXT

ItemDetailSource quality
Insurer partnersNot named in the 2026 coverage; consumer pages list Max Bupa and Star Health for personal plans; no source links Universal Sompo, Edelweiss or Tokio to PlumPlum pages; searches
OnsuritySubscription model for SMEs and startups; a snippet claims about US$66m raised, an older report gives a US$16m Series A led by QuonaConflict
Loop HealthPune; corporate groups of 100+ employees; CB Insights shows a US$25m round in April 2022Search result
AckoNo information found in the searchesNot published
IRDAI, Dec 2025Group health and group PA broker commissions moved to a principle-based framework set by insurers' board-approved policiesSnippet only
IRDAI, 2026Corporate-agent revision: brokers that do not apply by 31 March 2027 cease to act as brokers; TPA amendment around 30 July 2026 after a 19 June draft; October 2026 distribution reforms are proposalsSnippets only
Calculation (Rupeia)Result
Loop Health round against Plum's Series B25 ÷ 20.5 = 1.22x
Onsurity Series A against Plum's Series A16 ÷ 15.6 = 1.03x
Spread in Onsurity funding figuresUS$66m − US$16m = US$50m; the figures are not the same round
IRDAI TPA draft to amendment11 + 30 = 41 days (19 June to 30 July 2026)
Days to the broker deadline from this note142 days from 9 November 2026 to 31 March 2027 (21 in November, 31 in December, 31 in January, 28 in February, 31 in March)
RUPEIA READ Plum's model depends on insurers it has not named in the sources read, so who carries the claims risk on a given policy sits in the policy document. The IRDAI items come from search snippets, not full texts, and the October 2026 reforms are proposals. They matter because they affect broker economics and TPA rules, but how they apply to Plum is not published.

8 RISKS, SCENARIOS AND CHECKLIST

RiskEvidenceSeverityKill condition
Profit claimUnquantified; FY25 data shows a lossHIGHFilings show continuing losses
DisclosureNo valuation, stakes or structure publishedMEDIUMTerms prove unfavourable to common holders
Data conflictFY25 revenue ₹69.9 Cr against ₹13.9 CrMEDIUMLower figure is the filed one
Insurer dependenceUnderwriters not namedMEDIUMAn insurer limits group capacity
RegulationIRDAI broker and TPA changes in 2025 to 2026MEDIUMRegistration or commission rules tighten
CompetitionOnsurity and Loop Health in the same segmentMEDIUMPrice competition for employers
ScenarioWhat happensOutcome
BullFilings confirm the profit claim and the 10 million reach target is metFunding case strengthens
BaseRound funds product and claims automation; profit stays unquantifiedSlow disclosure
BearHigher FY25 revenue proves wrong and losses continueFurther funding needed
Investor classFitWhy
Private-markets investorPARTIALRecognised lead investor, but no valuation or audited profit published
Employer HR buyerWATCHInsurer partners and claims terms are not named
Insurtech researcherFITClear case study of a post-2021 group health platform

Rupeia does not recommend buying or selling any security and is not a SEBI-registered investment adviser or research analyst. Open items are the valuation, the stakes, the insurer partners, the profitability year and the filed FY25 figures, none of which is published in the sources read.

9 KEY TERMS USED IN THIS REPORT

The terms below are used in this report. Each is explained in plain words.

TermMeaning
Series BThe second major venture funding round, used to scale a proven product.
Group health insuranceOne policy covering many employees under their employer.
TPAThird-party administrator that handles claims for insurers.
IRDAIInsurance Regulatory and Development Authority of India, the insurance regulator.
EBITDAOperating profit before interest, tax, depreciation and amortisation.
Post-money valuationA company's value immediately after a funding round.

Frequently asked questions

How much did Plum raise in 2026?

Plum announced a Series B of ₹193 crore, about US$20.5 to 20.6 million, on 26 March 2026, led by Peak XV Partners.

Who invested in the Series B?

Peak XV Partners led. Tanglin Venture Partners, an existing investor, increased its stake, and GMO VenturePartners of Japan joined as a new investor.

What is Plum's valuation?

It is not published. Entrackr estimated a post-money of about US$87 million for the 2021 Series A; no figure is published for 2026.

Is Plum profitable?

The company says it had its first full year of EBITDA and cash-flow profitability, with no year or figures. Inc42's FY25 data shows a loss.

Who founded Plum?

Abhishek Poddar (co-founder and CEO) and Saurabh Arora, in 2019 per Inc42 and Entrepreneur India, or early 2020 per Entrackr.

Which insurers work with Plum?

Not named in the 2026 coverage. Plum's consumer pages list Max Bupa and Star Health for personal plans.

Source log

Inc42: Insurtech Startup Plum Nets ₹193 Cr To Expand Employee Health Benefits Platform

StartupTalky: Plum Raises ₹193 Crore Led by Peak XV Partners

Entrepreneur India: Plum Insurance Raises INR 193 Cr in Series B Led by Peak XV

Inc42: Plum financials page

fintech.global: Plum raises Series B to scale claims experience in India

fintech.global: Plum bags $15.6m from Tiger Global

DISCLAIMER This document is published strictly for informational, educational and academic record-keeping purposes. The publisher is not a SEBI Registered Investment Adviser (RIA) or Research Analyst (RA). It does not constitute personal investment advice, a financial recommendation, or an offer or solicitation to buy, sell or subscribe to any securities. Investments in the securities market are subject to market risks. Read all related documents carefully before investing.